AI-powered billing tools embedded in US hospital systems have already driven close to $1 billion in additional healthcare spending over two years, according to a Blue Cross Blue Shield Association (BCBSA) analysis. Insurers say AI-driven upcoding, billing a visit as more complex than it is, is inflating costs without improving care, while health premiums climb nationwide.
🔑 Key takeaways
- BCBSA estimates close to $1 billion in AI-driven cost overrun across 2024-2025
- In Texas, complex-coded admissions rose from 47% in 2022 to 60% in 2025
- Over $2 billion in national claims may be inflated by AI-assisted upcoding
- Texas health insurance premiums are up 7-9% driven by these practices
BCBSA study quantifies the AI cost overrun
Published in late September 2026 and covered by the New York Times and TechCrunch, the BCBSA analysis compares 2024 and 2025 against a 2023 baseline. The study found a sharp rise in the number of patients documented with complex conditions, with no corresponding change in actual care delivered.
Luke Chalker, senior vice president at BCBSA, said coding changes are driven by this technology. By adding a secondary diagnosis, such as anemia or hyponatremia (an imbalance of sodium in the blood), hospitals received on average nearly $12,000 more per case. Over two years, these surcharges amount to approximately $1 billion.
This trend reflects a fundamental shift in hospital billing practices. Facilities have deployed tools capable of systematically analyzing every encounter, a patient-provider visit, to maximize reimbursement from insurers and public programs.
How AI-powered upcoding works
Upcoding is the practice of billing a consultation or medical procedure as more complex than it actually is. With the rise of ambient AI tools (environmental listening systems), patient-doctor exchanges are now captured in real time, and higher billing codes are suggested automatically.
The Texas Association of Health Plans (TAHP) report dated March 30, 2026 quantifies the scale of the phenomenon: more than $2 billion in claims could already be inflated nationwide by these practices. In Texas, hospitals with the highest AI adoption rates saw their share of complex-coded admissions rise from 47% in 2022 to 60% in 2025, while upcoding grew 28% over three years.
| Indicator | Value |
|---|---|
| Complex admissions (Texas, 2022) | 47% |
| Complex admissions (Texas, 2025) | 60% |
| Upcoding growth (3 years) | +28% |
| New mothers diagnosed with postpartum anemia | +37% |
| Inpatient spending tied to AI codes | $663M |
| Outpatient spending tied to AI codes | $1.67B |
Over the same period, the number of new mothers diagnosed with postpartum anemia jumped 37%, while the number of treatments administered remained unchanged. In monetary terms, $663 million in inpatient (hospitalized) spending and $1.67 billion in outpatient (clinic) spending are already linked to inflationary codes generated by AI.
Direct impact on employers and premiums
Texas employers bear the brunt of these distortions. The TAHP reports premium increases of 7% to 9% for the current year, partly attributable to AI-amplified billing. These hikes are passed on to workers and families whose health coverage is becoming more expensive.
“The coding changes because of this technology.”
Luke Chalker, Senior Vice President, BCBSA
Insurers are beginning to push back. In Texas, health plans are using data analytics tools to detect upcoding patterns and recover overpayments. On the markets side, a Raymond James analyst suggested that hospitals seeking to improve margins will increasingly turn to AI coding tools to boost reimbursements from insurers and public programs.
Tech industry reactions and expert assessments
Reactions from the technology sector are mixed. Dr. Shiv Rao, founder of Abridge (a medical AI startup), acknowledged that current usage could lead to “a horrible dystopian future where bots fight against bots, agents against agents.” However, he tempered this by noting that AI could also reduce tensions and bring costs down.
Dr. David Brailer, a former government health official and technology executive, wrote in Health Affairs that AI “would lower the cost of the weapons in these billing battles,” but that it risks actually increasing overall healthcare spending.
Amol Navathe, senior research fellow at the Leonard Davis Institute at the University of Pennsylvania, noted that AI is “more adaptable and more variable than human services,” which complicates payment models based on time and skill. In a perspective published in Health Affairs in January 2026, Navathe and coauthors advocated for personalized payment pathways that incorporate a clinical benefit standard and tie compensation to health outcomes rather than volume of services.
“AI is more adaptable and more variable than human services, which complicates payment models built on time and skill.”
Amol Navathe, Leonard Davis Institute, University of Pennsylvania
These experts draw parallels to drug therapy, where the introduction of new molecules long drove costs higher before generic content policies and price negotiations restored balance.
Recommendations to curb the trend
Industry commentators have put forward several key recommendations:
- Greater transparency on how AI systems are actually used in billing and coding processes
- Applying the same rules to algorithmic tools as to human reviewers in billing decisions
- Aligning financial incentives with clinical outcomes rather than volume of services billed
- Personalized payment pathways incorporating a clinical benefit standard, per Navathe and coauthors
The absence of such safeguards exposes employers, patients, and the entire healthcare system to persistent cost inflation. Without changes to payment policies, AI risks increasing costs without improving care.
Conclusion: AI-driven healthcare inflation hinges on regulation
Current data shows that AI tools used by hospitals to optimize their revenue cycle have already generated hundreds of millions of dollars in additional spending in the United States. The AI-fueled upcoding phenomenon is growing rapidly and is beginning to translate into premium hikes for businesses and individuals alike.
If insurers and regulators do not intervene with appropriate control and payment mechanisms, the trend is likely to intensify in the coming years. Two scenarios emerge: an optimistic one where regulators mandate transparency and realign financial incentives with clinical outcomes, and a pessimistic one where the AI-versus-insurer escalation in “billing battles” permanently weighs on the cost of healthcare.
Sources
- TechCrunch
- Texas Association of Health Plans
- The New York Times
- Leonard Davis Institute, University of Pennsylvania
- DocWire News
- MoyanAI
This article is published for informational and educational purposes. It does not constitute investment advice in any form. Conduct your own research (DYOR) before making any decisions.
